Cardioprotective Activity of 2,6-Diisobornyl-4-Methylphenol in Acute Myocardial Ischemia/Reperfusion in Rats


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We studied the cardioprotective effect of 2,6-diisobornyl-4-methylphenol under conditions of myocardial ischemia/reperfusion in rats. Daily administration of 2,6-diisobornyl-4-methylphenol (100 mg/kg intragastrically) over 3 days before and 5 days after modeling of myocardial ischemia/reperfusion prevented the increase in the infarction area by almost 2 times in comparison with the control by day 5 after recirculation. The type and severity of pathological changes in ECG parameters reflecting necrotic changes in the myocardium under the action of the compound significantly decreased by day 35 of the experiment. Animal survival rate during the first 24 h after ischemia/reperfusion modeling in the experimental group was by 29% higher than in the control group.

About the authors

T. M. Plotnikova

Siberian State Medical University, Ministry of Health of Russia

Author for correspondence.
Email: plot160@mail.ru
Russian Federation, Tomsk

G. A. Chernysheva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: plot160@mail.ru
Russian Federation, Tomsk

V. A. Smol’yakova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: plot160@mail.ru
Russian Federation, Tomsk

P. P. Shchetinin

National Research Tomsk State University

Email: plot160@mail.ru
Russian Federation, Tomsk

A. V. Kuchin

Institute of Chemistry, Komi Research Center, Ural Division of the Russian Academy of Sciences

Email: plot160@mail.ru
Russian Federation, Syktyvkar, Komi Republic

I. Yu. Chukicheva

National Research Tomsk State University

Email: plot160@mail.ru
Russian Federation, Tomsk

M. B. Plotnikov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: plot160@mail.ru
Russian Federation, Tomsk


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies